Enteric Bacteria and Non-Intestinal Health
Page 1
Enteric Bacteria and Non-intestinal Health
Dr. Hazel Girvan
Page 2
Recap of What You Already Know
- Inflammatory Bowel Disease (IBD) consists of Crohn’s disease (CD) and Ulcerative Colitis (UC).
- Genetics, immune system and environment all play critical roles in both diseases.
- Crohn’s disease: Can affect any part of the gastrointestinal tract; lesions can extend through the cell wall.
- Ulcerative colitis: Affects solely the colon and mostly the mucosal surface.
- Symptoms overlap between the two, with CD patients often experiencing issues related to impaired small intestine function (e.g., weight loss, growth reduction in children).
- Studies on twins show a strong concordance in CD and an identifiable hereditable component in UC, with key genes identified.
- Notably, NOD2 is linked to CD and acts as an intracellular receptor for bacterial components, triggering inflammatory pathways.
- Damage to the mucous layer of epithelial cells increases pathogen access, leading to inflammation.
- Damage to epithelial junctions allows greater uptake of antigens and activates proinflammatory cytokine pathways through toll-like receptors.
- Environmental impact: Sterile mice with genetic predispositions for CD only develop the disease when exposed to bacteria.
- Medical therapies include:
- Aminosalicylates: Inhibit pro-inflammatory factors.
- Corticosteroids: Regulate inflammation.
- Biological agents: Target TNF, integrins or interleukins.
Page 3
Learning Objectives
- Conditions affiliated with enteric GI microbiota.
- Current evidence and proposed mechanisms.
- The role of probiotics in gastrointestinal health.
Page 4
Introduction
- Historical links exist between fermented foods and health from ancient Egyptian times; however, systematic scientific exploration is relatively recent.
- Establishing cause and effect is complex due to commercialization and lack of regulation concerning probiotics, leading to unsubstantiated health claims.
Page 5
The Microbiota
- Composed of diverse microorganisms in various body sites (e.g., GI tract, skin, lungs).
- Provides over 150 times more genetic data than the human genome.
- Composition varies between sites and depends on factors such as age and environmental influences.
- Microbiota: Living microorganisms in a defined environment; Microbiome: Genomic information of all microorganisms present.
Page 6
Healthy Gut Microbiota
- An abundant microbial community with ~100 trillion microorganisms and high taxonomical diversity.
- Contains 100 times more genes than the human genome, unique to each individual and subject to variation due to age and environmental factors.
Page 7
Roles of a Healthy GI Microbiota
- Extract energy from indigestible dietary materials via fermentation, producing short-chain fatty acids (SCFAs).
- Stimulate immune responses and produce vitamins (e.g., K, B6, B12).
- Influence bile acid production to protect against pathogens.
- Gut microbiota metabolites can comprise up to 10% of total blood metabolites in mammals.
Page 8
Short-chain Fatty Acids (SCFAs)
- Includes acetate, propionate, butyrate, etc.
- Influence gut barrier function, appetite, energy metabolism, and systemic immune response.
- Links to conditions like diabetes, obesity, and IBD.
Page 9
Implications of Gut Metabolism
- Toxic compounds may leak from the intestine due to increased permeability.
- Bacterial molecules (e.g., lipopolysaccharide) can induce immune responses.
- Chronic inflammation poses systemic effects, including those on the central nervous system (CNS).
Page 10
Lipopolysaccharide and Toll-like Receptors
- LPS, a component of Gram-negative bacteria, engages with TLRs triggering cytokine cascades and inflammatory responses.
Page 11
Short-chain Fatty Acids (SCFAs)
- Produced from dietary fiber digestion; they bind to specific GPCRs and histone deacetylases, promoting anti-inflammatory effects.
Page 12
Bile Acids
- Primary bile acids synthesized from cholesterol in the liver and released for digestion; secondary bile acids formed via colonic bacteria process.
Page 13
Trimethylamine and Trimethylamine N-oxide
- Found in red meat and eggs; microbial enzymes convert these precursors to TMA and subsequently TMAO in the liver.
Page 14
Impacts of Gut Health Dynamics
- Healthy interactions in the gut result in improved digestion, regulation of inflammation, and metabolic homeostasis across various body systems.
Page 15
Diseases Linked to the Microbiota
- Includes: metabolic disorders (e.g. obesity, type 2 diabetes), allergies, autoimmune diseases, psychological health conditions (e.g. autism, multiple sclerosis), and cardiovascular diseases.
Page 16
Overview of Microbiota-Linked Diseases
- The relationship between microbiota and diseases is complex and evolving.
- Dysbiosis indicates an imbalance in microbiota that can lead to various health issues.
Page 17
Microbiota Changes in Diseases
- There is strong associative data indicating microbiota changes may be symptoms or causes of specific disease states.
Page 18
IBD and Microbiota
- Notable decrease in species richness and bacterial diversity in inflamed mucosal areas observed in IBD patients emerging as a potential target for treatment.
Page 19
NOD2 Mutation in CD Patients
- A mutation leads to decreased levels of anti-inflammatory cytokines, illustrated by NOD2 deficient mice that display a higher susceptibility to colitis under germ-free conditions.
Page 20
Mechanistic Links in Specific Diseases
- Further insights needed to understand the complex connections involving GI dysbiosis and various diseases.
Page 21
Cardiovascular Diseases and Dysbiosis
- The connections to specific cardiovascular diseases are notable through pathways influenced by GI microbiota composition.
Page 22
Trimethylamine N-oxide (TMAO)
- Elevated levels associated with diets high in choline and carnitine contribute to cardiovascular disease risk.
Page 23
LPS and Atherosclerosis
- LPS can activate inflammatory responses contributing to the formation of atherosclerotic plaques.
Page 24
The Gut-Brain Axis (GBA)
- Interconnections exist in brain functions including memory and mood, direct impacts on mental health behaviors and outcomes are significant from gut metabolites.
Page 25
Neurological Disease and Microbiota Alterations
- Significant dysbiosis observed in neurological patients impacting disease progression and behaviors.
Page 26
HPA Axis Modulation
- Animal studies link stress from HPA activation to increased gut permeability and dysbiosis related to psychological disorders.
Page 27
Alzheimer’s Disease and Gut Health
- Age-related dysbiosis may predict altered microbial profiles linked to neuroinflammation and Alzheimer's risk.
Page 28
Type II Diabetes Mechanisms
- Involvement of gut microbiota in modulating inflammation and glucose metabolism provides insights into diabetes mechanisms.
Page 29
Fatty Acid Metabolism in Type II Diabetes
- Short-chain fatty acids can promote energy expenditure and enhance metabolic processes linked to glucose efficacy.
Page 30
Gut & Obesity Signalling
- Gut hormones play crucial roles in signals for hunger and satiety impacting hormone-mediated eating behaviors.
Page 31
Evidence of Obesogenic Microbiomes
- Shifts in microbiota composition may strongly predict obesity outcomes based on metabolic shifts observed.
Page 32
Gut Dysbiosis and Weight Correlation
- Significant shifts observed in microbial communities indicate risks and predispositions to weight gain.
Page 33
Effects of SCFAs and Metabolites on Hosts
- Produced SCFAs activate various receptors influencing metabolic pathways critical for maintaining homeostasis.
Page 34
Probiotics and Prebiotics in Systemic Health
- Diverse microbiota supports overall health benefits including reduced inflammation and balanced gut permeability.
Page 35
Therapeutic Interventions via the Microbiome
- Potential interventions include diet adjustments, use of probiotics, and metabolic support for health outcomes.
Page 36
Probiotics, Prebiotics, and Synbiotics
- Probiotics are live microorganisms that provide health benefits when taken in adequate amounts, with clinical evidence supporting their viability in health promotion.
Page 37
Treatment of IBD via Microbiota Management
- Microbial signatures serve as diagnostic tools, although findings on fecal transplants in humans remain inconclusive.
Page 38
Probiotics and Cardiovascular Health
- Synergistic roles in disease prevention linked to cholesterol mechanisms and inflammation regulation are emerging.
Page 39
Cancer and Probiotics
- Probiotics may influence cancer risk through immune modulation and influencing the microbiota related to colorectal cancer.
Page 40
Conclusion
- The pathways through which enteric bacteria affect health are intricate, involving direct neural communication and biochemical interactions influencing various body processes.
Page 41
Gut Microbiota Strains
- Diversity of strains found in different parts of the gut impacts functionality and interactions with bodily systems, interconnected with health outcomes from the gut.
Page 42
Dietary Impacts on Gut Health
- Various dietary components influence gut microbiota health with differential impacts on systemic inflammation, CVD risks, and overall health outcomes.